In addition, a growing body of evidence suggests that transfusing larger volumes of ABO “compatible,” but non-identical plasma is associated with an increase in complications such as sepsis, acute respiratory distress syndrome (ARDS), and mortality [5,6]. This evidence concerns the gene ABO and acute respiratory distress syndrome.